NCT05415618

Brief Summary

Carpal tunnel syndrome (CTS) occurs as a result of compression of the median nerve under the transverse ligament along the carpal tunnel. The main cause of median nerve compression and carpal tunnel syndrome is increased volume in the carpal tunnel. The pressure that edema puts on the nerve must be controlled in the early period. Edema that persists beyond the inflammatory process can contribute to the fibrotic stage, delay healing, and even cause complications such as pain and stiffness. Manual lymphatic drainage (MLD) is a specialized technique that involves gentle massage techniques and follows lymphatic pathways from proximal to distal and then from distal to proximal. On the basis of this concept; Increasing circulation by stimulating the lymph system, removing biochemical residues, reducing edema and pain, and regulating sympathetic and parasympathetic system responses. It is known that MLD rapidly regulates lymphatic circulation by creating a change in interstitial fluid pressure, thus preventing even arthrofibrotic tissue that may form after a traumatic situation, reducing edema that predisposes to pain, and increasing mobility. Nerve gliding exercises are another method used in treatment. By providing a sliding movement of the tendons and median nerve in the distal-proximal direction, mobilization of the surrounding soft tissues is achieved and dynamic ischemia is terminated. The aim of this study is to determine the effectiveness of manual lymphatic drainage and nerve mobilization on clinical and ultrasonographic findings in carpal tunnel syndrome.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 13, 2022

Completed
1.7 years until next milestone

Study Start

First participant enrolled

March 12, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2024

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

1 month

First QC Date

June 8, 2022

Last Update Submit

March 12, 2024

Conditions

Keywords

ultrasonographic evaluationcarpal tunnel syndromemanual lymph drainageedemapain

Outcome Measures

Primary Outcomes (2)

  • Ultrasonographic Evaluation

    Median nerve diameter measurements and depths of the participants will be made by USG with a multifrequency (7-15 MHz) linear probe. With USG, the median CBF and its depth will be measured distally from the level of the scaphoid bone (wrist; carpal tunnel level) and the midpoint of the forearm.

    20 minutes

  • Evaluation of symptom severity and functional status

    It will be assessed with the Boston Carpal Tunnel Questionnaire (BCTQ). 1. The symptom severity scale (BCTQSS) has 11 items that evaluate pain, paresthesia, and weakness. 2. The functional status scale (BCTQ-FS) evaluates the ability to perform manual activities with 8 items. Each item evaluates the increasing severity of symptoms or difficulty with a higher score.

    10 minutes

Study Arms (3)

Kontrol group

ACTIVE COMPARATOR
Device: splint

MLD group

EXPERIMENTAL
Other: Manual lymphatic drainage

Nerve gliding group

EXPERIMENTAL
Other: Nerve gliding

Interventions

Manual lymphatic drainage will be applied 5 days a week for about 15 minutes every day for 4 weeks.

MLD group
splintDEVICE

In splint treatment, a volar-supported splint that keeps the wrist in a neutral position will be preferred and it will be recommended to both groups to be used only at night for 4 weeks.

Kontrol group

Median nerve gliding exercises as a home exercise program will be performed by the patient 5 days a week for 4 weeks. It will be performed in 6 different consecutive positions of the hand and wrist.

Nerve gliding group

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of mild to moderate carpal tunnel syndrome on electrodiagnostic examination
  • Being between 20-55 years old
  • Volunteering to participate in the treatment to be given

You may not qualify if:

  • Have a systemic inflammatory disease
  • Having any disease that may cause polyneuropathy, such as diabetes mellitus
  • Cognitive impairment
  • Receiving psychotherapy
  • Having a pacemaker
  • illiterate
  • Having a disease affecting the central nervous system
  • Having a hearing problem
  • Any skin disease that would contraindicate manual lymphatic drainage
  • Arterial or venous circulatory disorders that would contraindicate manual lymphatic drainage
  • NSAID drug use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Science University Hospital

Kütahya, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Carpal Tunnel SyndromeEdemaPain

Interventions

Manual Lymphatic DrainageSplints

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurologic Manifestations

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsDrainagePhysical Therapy ModalitiesRehabilitationExternal FixatorsOrthopedic Fixation DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesSurgical Fixation Devices

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 8, 2022

First Posted

June 13, 2022

Study Start

March 12, 2024

Primary Completion

April 12, 2024

Study Completion

April 30, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Locations